Fig. 4From: The contribution of single-cell analysis of acute leukemia in the therapeutic strategyWhen co-occurrence of multidrug resistance mechanisms at LSC level, classical chemotherapy (+/− sensitizing drugs) will remain useful with the debulking and clonal heterogeneity reduction effects, still allowing the use of targeted therapy followed by passive or active immunotherapyBack to article page